194 related articles for article (PubMed ID: 29673058)
1. Pediatric heart transplantation across a positive crossmatch: First year results from the CTOTC-04 multi-institutional study.
Webber S; Zeevi A; Mason K; Addonizio L; Blume E; Dipchand A; Shaddy R; Feingold B; Canter C; Hsu D; Mahle W; Armstrong B; Morrison Y; Ikle D; Diop H; Odim J;
Am J Transplant; 2018 Sep; 18(9):2148-2162. PubMed ID: 29673058
[TBL] [Abstract][Full Text] [Related]
2. Study rationale, design, and pretransplantation alloantibody status: A first report of Clinical Trials in Organ Transplantation in Children-04 (CTOTC-04) in pediatric heart transplantation.
Zuckerman WA; Zeevi A; Mason KL; Feingold B; Bentlejewski C; Addonizio LJ; Blume ED; Canter CE; Dipchand AI; Hsu DT; Shaddy RE; Mahle WT; Demetris AJ; Briscoe DM; Mohanakumar T; Ahearn JM; Iklé DN; Armstrong BD; Morrison Y; Diop H; Odim J; Webber SA
Am J Transplant; 2018 Sep; 18(9):2135-2147. PubMed ID: 29446208
[TBL] [Abstract][Full Text] [Related]
3. Incidence, characterization, and impact of newly detected donor-specific anti-HLA antibody in the first year after pediatric heart transplantation: A report from the CTOTC-04 study.
Dipchand AI; Webber S; Mason K; Feingold B; Bentlejewski C; Mahle WT; Shaddy R; Canter C; Blume ED; Lamour J; Zuckerman W; Diop H; Morrison Y; Armstrong B; Ikle D; Odim J; Zeevi A;
Am J Transplant; 2018 Sep; 18(9):2163-2174. PubMed ID: 29442424
[TBL] [Abstract][Full Text] [Related]
4. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
[TBL] [Abstract][Full Text] [Related]
6. The results of HLA-incompatible kidney transplantation according to pre-transplant crossmatch tests: Donor-specific antibody as a prominent predictor of acute rejection.
Kwon H; Kim YH; Kim JY; Choi JY; Shin S; Jung JH; Park SK; Han DJ
Clin Transplant; 2019 May; 33(5):e13533. PubMed ID: 30864255
[TBL] [Abstract][Full Text] [Related]
7. Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy.
Holt DB; Lublin DM; Phelan DL; Boslaugh SE; Gandhi SK; Huddleston CB; Saffitz JE; Canter CE
J Heart Lung Transplant; 2007 Sep; 26(9):876-82. PubMed ID: 17845925
[TBL] [Abstract][Full Text] [Related]
8. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
9. Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.
Schwaiger E; Eskandary F; Kozakowski N; Bond G; Kikić Ž; Yoo D; Rasoul-Rockenschaub S; Oberbauer R; Böhmig GA
Nephrol Dial Transplant; 2016 Aug; 31(8):1342-51. PubMed ID: 27190362
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes of Lung Transplantation in the Presence of Donor-Specific Antibodies.
Courtwright AM; Cao S; Wood I; Mallidi HR; Kawasawa J; Moniodis A; Ng J; El-Chemaly S; Goldberg HJ
Ann Am Thorac Soc; 2019 Sep; 16(9):1131-1137. PubMed ID: 31026404
[No Abstract] [Full Text] [Related]
11. Donor-specific HLA alloantibodies: Impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation.
Tran A; Fixler D; Huang R; Meza T; Lacelle C; Das BB
J Heart Lung Transplant; 2016 Jan; 35(1):87-91. PubMed ID: 26422083
[TBL] [Abstract][Full Text] [Related]
12. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
[TBL] [Abstract][Full Text] [Related]
14. Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatch.
Higgins R; Lowe D; Hathaway M; Williams C; Lam FT; Kashi H; Tan LC; Imray C; Fletcher S; Chen K; Krishnan N; Hamer R; Daga S; Edey M; Zehnder D; Briggs D
Transplantation; 2011 Oct; 92(8):900-6. PubMed ID: 21968524
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of Pretransplant Donor-Specific Antibodies in the Setting of Negative Cell-Based Flow Cytometry Crossmatching in Kidney Transplant Recipients.
Adebiyi OO; Gralla J; Klem P; Freed B; Davis S; Wiseman AC; Cooper JE
Am J Transplant; 2016 Dec; 16(12):3458-3467. PubMed ID: 27140940
[TBL] [Abstract][Full Text] [Related]
16. Understanding the Correlation Between DSA, Complement Activation, and Antibody-Mediated Rejection in Heart Transplant Recipients.
Zhang Q; Hickey M; Drogalis-Kim D; Zheng Y; Gjertson D; Cadeiras M; Khuu T; Baas AS; Depasquale EC; Halnon NJ; Perens G; Alejos J; Cruz D; Ali N; Shemin R; Kwon M; Fishbein MC; Ardehali A; Deng M; Reed EF
Transplantation; 2018 Oct; 102(10):e431-e438. PubMed ID: 29916988
[TBL] [Abstract][Full Text] [Related]
17. Kidney paired donation in the presence of donor-specific antibodies.
Blumberg JM; Gritsch HA; Reed EF; Cecka JM; Lipshutz GS; Danovitch GM; McGuire S; Gjertson DW; Veale JL
Kidney Int; 2013 Nov; 84(5):1009-16. PubMed ID: 23715120
[TBL] [Abstract][Full Text] [Related]
18. Impact of donor-specific anti-HLA antibody on cardiac hemodynamics and graft function 3 years after pediatric heart transplantation: First results from the CTOTC-09 multi-institutional study.
Webber SA; Chin H; Wilkinson JD; Armstrong BD; Canter CE; Dipchand AI; Dodd DA; Feingold B; Lamour JM; Mahle WT; Singh TP; Zuckerman WA; Rossano JW; Morrison Y; Diop H; Demetris AJ; Bentlejewski C; Mohanakumar T; Odim J; Zeevi A;
Am J Transplant; 2023 Dec; 23(12):1893-1907. PubMed ID: 37579817
[TBL] [Abstract][Full Text] [Related]
19. Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome.
Senev A; Coemans M; Lerut E; Van Sandt V; Daniëls L; Kuypers D; Sprangers B; Emonds MP; Naesens M
Am J Transplant; 2019 Mar; 19(3):763-780. PubMed ID: 30107078
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
